Global Wholehealth Partners Corp. (GWHP)

[resx18]

LMAO .. call ?? really? Do you know how long you are going to be on hold for ? Just chill out bro .. the company comes through with one big update and we will fly imho. #Cheers M8

[resx18]

Good Evening $GWHP

[sanscuba]

Time to call investigations and the SEC. Where is the money trail going.
Hope for jail. Bleeding this company down to nothing. Call the company and see if they answer???? Go by the office and see if they are open???? Is it a shell company???? If the price doesn't go go soon I will figure I got scamed for tens of thousands. Please let me know other feedback here as well. Where is the update to the website selling products????? WTF
[/

[chancho3]

Sinking to a 52 week low with all the dilution Ive never had so much fun loosing my ASS!!! WTF!!!

[resx18]

Global WholeHealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases, with an FDA Certificate of Exportability (2260-11-2019). The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.
GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. Notably, The Company offers 56 products FDA approved and many are Approved for OTC use, and 15 POC products approved by the CLIA WAIVED FDA.

[resx18]

San Clemente, CA, May 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest lines of COVID 19 tests. Global WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses. The strains identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) strain contains multiple mutations, most reflected in the S gene, which encodes the spike protein. Global understands the need to be ahead of the virus to conquer the virus.
Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.
Global WholeHealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases, with an FDA Certificate of Exportability (2260-11-2019). The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.
GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. Notably, The Company offers 56 products FDA approved and many are Approved for OTC use, and 15 POC products approved by the CLIA WAIVED FDA.

[resx18]

Awesome news! $GWHP

[Finditdotcom]

News out on GWHP

Global is Going Mobile; Global WholeHealth Partners Corp (GWHP-OTC) has Signed an Agreement With Dr. Vu Le to be the Medical Director for the CLIA WAIVED Mobile Laboratory


https://finance.yahoo.com/news/global-going-mobile-global-wholehealth-110000449.html

Recent Interview with Charles Strongo

[resx18]

$GWHP - Global is Going Mobile; Global WholeHealth Partners Corp (GWHP-OTC) has Signed an Agreement With Dr. Vu Le to be the Medical Director for the CLIA WAIVED Mobile Laboratory

https://marketwirenews.com/news-releases/global-is-going-mobile-global-wholehealth-partners-c-4662425512697500.html

[resx18]

Global WholeHealth Partners Corp (GWHP: OTC) is bringing the testing to you, to your school or to your work.  8k filed on 05/14/2021.
Global will be using this CLIA WAIVED Lab to test for COVID 19 Antigen, Antibody, and the other 15 tests that are CLIA WAIVED that Global carries.
San Clemente, CA, May 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest lines of COVID 19 tests. Global WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses.  The strains identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) strain contains multiple mutations, most reflected in the S gene, which encodes the spike protein. Global understands the need to be ahead of the virus to conquer the virus.
Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.
Global WholeHealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases, with an FDA Certificate of Exportability (2260-11-2019).  The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.
GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. Notably, The Company offers 56 products FDA approved and many are Approved for OTC use, and 15 POC products approved by the CLIA WAIVED FDA.
Media Contact:
Name: Charles Strongo,
CEO, Global WholeHealth Partners Corp.
Email: [e-mail]
www.gwhpcorp.com

[resx18]

Good Morning GWHP

[Buy High Sell Now]

“This is a wartime undertaking,” President Biden said. “Today, I’m signing executive action to use the Defense Production Act and all other available authorities to direct all federal agencies and private entities to accelerate the making of everything that’s needed to protect, test, vaccinate, and take care of our people.” https://philadelphia.cbslocal.com/2021/01/21/president-joe-biden-country-at-war-coronavirus/

[Buy High Sell Now]

“This is a wartime undertaking,” Biden said. “Today, I’m signing executive action to use the Defense Production Act and all other available authorities to direct all federal agencies and private entities to accelerate the making of everything that’s needed to protect, test, vaccinate, and take care of our people.” https://philadelphia.cbslocal.com/2021/01/21/president-joe-biden-country-at-war-coronavirus/

[Buy High Sell Now]

Global Wholehealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.

[Buy High Sell Now]

As a third surge of the coronavirus threatens much of the United States, public health experts across the country say there still aren’t enough tests available to keep the virus under control.

About 30 million Covid-19 tests are given every month, according to estimates from The Atlantic magazine’s Covid Tracking Project. But studies have found that the U.S. would need millions more —193 million a month, according to one report — to be effective.

[Animalbar]

got some good DD here $GWHP

[Animalbar]

GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. Notably, GWHP offers a CE Mark for its high quality, rapid antibody test for COVID-19 and an EUA filing with the FDA is pending approval. In the interim, the US Navy in California has been using the test during 2Q20 and the Company has the capacity to deliver hundreds of thousands of tests, ramping up to 1 million per day. Currently, the Company has 56 products FDA approved and many are Approved for OTC use, and 9 POC products approved by the FDA.

[Animalbar]

Global Wholehealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and other vector borne diseases. The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.

[Animalbar]

The USA has the largest number of Covid-19 cases in the world and there is concern that this next wave of infections will be worse than the previous. Global WholeHealth Partners, Corp. is confident that its Covid-19 Rapid Test can make a difference through assisting companies, staff, and public places where transmission may occur with a reliable, accurate, and fast Rapid Test.

[Animalbar]

About 30 million Covid-19 tests are given every month, according to estimates from The Atlantic magazine’s Covid Tracking Project. But studies have found that the U.S. would need millions more —193 million a month, according to one report — to be effective.

[Animalbar]

The market is growing because of the outbreak of the coronavirus (SARS CoV-2) pandemic, which has increased the demand for rapid testing across the world. As the number of people suffering from the viral infection increases, the demand for rapid testing, which allows detecting the virus quickly, is growing. The adoption of a population-wide testing approach, which includes household, individual testing, is one of the trends influencing the demand for covid-19 diagnostics kits. The shift from symptomatic testing to mass testing in developed countries is another major factor affecting the market.

[Buy High Sell Now]

The USA has the largest number of Covid-19 cases in the world and there is concern that this next wave of infections will be worse than the previous. Global WholeHealth Partners, Corp. is confident that its Covid-19 Rapid Test can make a difference through assisting companies, staff, and public places where transmission may occur with a reliable, accurate, and fast Rapid Test.

Global WholeHealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.

[Buy High Sell Now]

The market is growing because of the outbreak of the coronavirus (SARS CoV-2) pandemic, which has increased the demand for rapid testing across the world. As the number of people suffering from the viral infection increases, the demand for rapid testing, which allows detecting the virus quickly, is growing. The adoption of a population-wide testing approach, which includes household, individual testing, is one of the trends influencing the demand for Covid-19 diagnostics kits. The shift from symptomatic testing to mass testing in developed countries is another major factor affecting the market.

[Buy High Sell Now]

Under Mr. Strongo’s direction, Global is following the President and his leadership and is making a war on COVID. To conquer COVID and win this war, Global must keep up the research and development of tests.

Mr. Strongo states, “Global continues to do research on all new strains of the COVID-19 virus to make sure the tests we offer are a useful and reliable diagnostic test."

[Buy High Sell Now]

“This is a wartime undertaking,” President Biden said. “Today, I’m signing executive action to use the Defense Production Act and all other available authorities to direct all federal agencies and private entities to accelerate the making of everything that’s needed to protect, test, vaccinate, and take care of our people.” https://philadelphia.cbslocal.com/2021/01/21/president-joe-biden-country-at-war-coronavirus/

[Buy High Sell Now]

San Clemente, CA, Feb. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest line of COVID 19 tests. Global WholeHealth Partners Corp (OTC: GWHP) offers an Antibody IgG/IgM test capable of detecting all the current identified SARS-CoV-2 viruses. The strains identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) contain multiple mutations, most reflected in the S gene, which encodes the spike protein. Global understands the need to be ahead of the virus to conquer the virus.

[Animalbar]

Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.

With results in minutes versus hours or days with other diagnostic kits, the more lives that can be saved with the only FDA authorized COVID-19 POC serology Point of Care Test. With the new fingerstick test, healthcare providers can prick a patient's finger and get results in minutes without having to wait for venous blood. Global WholeHealth Partners will be able to distribute these tests to more urgent cares, hospitals, and - to help curb the spread of CoViD19 SARS2.

[Animalbar]

"The CDC is still recommending that individuals who are already fully vaccinated for the COVID-19 virus continue to get tested if they are experiencing any of the symptoms," Charles Strongo reiterated.

CDC Recommendations for Fully Vaccinated People can be found here.

[Animalbar]

A copy of the Global WholeHealth Partners, Corp 8K filing dated 03/02/2021 related to the distribution rights of the AstraZeneca vaccine can be found here.

[Animalbar]

White House press secretary Jen Psaki recently said "We want to be oversupplied and over prepared," saying Biden wanted contingencies in the event of any unforeseen issues with the existing production timeline.

[Animalbar]

Charles Strongo, CEO of Global WholeHealth Partners, Corp. said, "We were so impressed by the progress that AstraZeneca has made thus far with their vaccine, that we (Global) have secures the distribution rights to sell this vaccine anywhere in the world."

[Buy High Sell Now]

nice info here $GWHP

[Buy High Sell Now]

Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.

[Buy High Sell Now]

The market is growing because of the outbreak of the coronavirus (SARS CoV-2) pandemic, which has increased the demand for rapid testing across the world. As the number of people suffering from the viral infection increases, the demand for rapid testing, which allows detecting the virus quickly, is growing. The adoption of a population-wide testing approach, which includes household, individual testing, is one of the trends influencing the demand for Covid-19 diagnostics kits. The shift from symptomatic testing to mass testing in developed countries is another major factor affecting the market.

[Animalbar]

money never sleeps $ $ $

[Buy High Sell Now]

Animal with that late night $GWHP DD

[Animalbar]

Nutritional deficiencies: Not drinking enough liquids (dehydration); not getting enough thiamin (vitamin B-1), which is common in people with chronic alcoholism; and not getting enough vitamins B-6 and B-12 in your diet can cause dementia-like symptoms. Copper and vitamin E deficiencies also can cause dementia symptoms: https://www.mayoclinic.org/diseases-conditions/dementia/symptoms-causes/syc-20352013. “Early detection for Dementia disease is not only crucial for patients and their quality of life, but this data is also used by researchers to seek out commonalities, causes and hopefully cures,” commented Strongo.

[Animalbar]

“We believe this announcement couldn’t come at a better time for us as we are partnering with Nunzia Pharmaceutical and their products for Neurological disorders,” said Mr. Strongo. “Nunzia Pharmaceutical with nutraceutical for anxiety and stress based on their patented formula and their pharmaceutical drug they are planning on bringing through the FDA, which specifically works on the Hippocampus part of the brain, dealing with stress, memory, and fine motor skills are a perfect fit for Global’s diagnostic tests,” says Mr. Strongo.

[resx18]

Have a great night!!

[resx18]

Let's have a huge day tomorrow

[Animalbar]

GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. The Company has the capacity to deliver hundreds of thousands of tests, and can ramp up to 1 million tests per day. Currently, the Company has 56 products FDA approved and many are Approved for OTC use, and 9 POC products approved by the FDA.

[Animalbar]

Mr. Charles Strongo, the Chairman and CEO of Global WholeHealth Partners Corp, said, "The Company's goal is to offer the fastest and most reliable in-vitro diagnostic tests on the market, while keeping ahead in R&D, by offering FDA Approved Troponin I Whole Blood, Influenza A & B, and Strep A. The Company also has international testing, which is not sold in the USA, with an FDA Certificate of Exportability (2260-11-2019) for tests like ZIKA, Rapid Ebola, Rapid Dengue Fever Antibody, and Antigen, Rapid Tuberculosis (TB), Rapid Malaria, and many other rapid tests."

[Animalbar]

About 1 in 54 children has been identified with autism spectrum disorder (ASD) according to estimates from CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network.

[Animalbar]

About 1 in 6 (17%) children aged 3–17 years were diagnosed with a developmental disability, as reported by parents, during a study period of 2009-2017. These included autism, attention-deficit/hyperactivity disorder, blindness, and cerebral palsy, among others.

[Buy High Sell Now]

Yessir $GWHP big move intentions here

[Buy High Sell Now]

Couldnt have said it better my man $GWHP

[resx18]

Great DD today!

[Animalbar]

SLAP

[Animalbar]

THAT

[Animalbar]

ASK